Ruthenium-catalyzed ester reductions applied to pharmaceutical intermediates

Shaalan, Youssef and Boulton, Lee and Jamieson, Craig (2020) Ruthenium-catalyzed ester reductions applied to pharmaceutical intermediates. Organic Process Research and Development, 24 (11). pp. 2745-2751. ISSN 1083-6160

[thumbnail of Shaalan-etal-OPRD-2020-Ruthenium-catalyzed-ester-reductions-applied-to-pharmaceutical]
Preview
Text (Shaalan-etal-OPRD-2020-Ruthenium-catalyzed-ester-reductions-applied-to-pharmaceutical)
Shaalan_etal_OPRD_2020_Ruthenium_catalyzed_ester_reductions_applied_to_pharmaceutical.pdf
Accepted Author Manuscript

Download (759kB)| Preview

    Abstract

    Ruthenium pincer complexes were synthesized and used for catalytic ester reductions under mild conditions (∼5 bar of hydrogen). An experimental design approach was used to optimize the conditions for yield, purity, and robustness. Evidence for the catalytically active ruthenium dihydride species is presented. Observed intermediates and side products, as well as time-course data, were used to build mechanistic insight. The optimized procedure was further demonstrated through scaled-up reductions of two pharmaceutically relevant esters, both in batch and continuous flow.

    ORCID iDs

    Shaalan, Youssef, Boulton, Lee and Jamieson, Craig ORCID logoORCID: https://orcid.org/0000-0002-6567-8272;